The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis
Open accessAbstract
Since bone metastatic breast cancer is an incurable disease, causing significant morbidity and mortality, an understanding of the underlying molecular mechanisms would be highly valuable. Here, we describe in vitro and in vivo evidences for the importance of serine biosynthesis in the metastasis of breast cancer to bone. We first characterized the bone metastatic propensity of the MDA-MB-231(SA) cell line variant as compared to the parental MDA-MB-231 cells by radiographic and histological observations in the inoculated mice. Genome-wide gene expression profiling of this isogenic cell line pair revealed that all the three genes involved in the L: -serine biosynthesis pathway, phosphoglycerate dehydrogenase (PHGDH), phosphoserine aminotransferase 1 (PSAT1), and phosphoserine phosphatase (PSPH) were upregulated in the highly metastatic variant. This pathway is the primary endogenous source for L: -serine in mammalian tissues. Consistently, we observed that the proliferation of MDA-MB-231(SA) cells in serine-free conditions was dependent on PSAT1 expression. In addition, we observed that L: -serine is essential for the formation of bone resorbing human osteoclasts and may thus contribute to the vicious cycle of osteolytic bone metastasis. High expression of PHGDH and PSAT1 in primary breast cancer was significantly associated with decreased relapse-free and overall survival of patients and malignant phenotypic features of breast cancer. In conclusion, high expression of serine biosynthesis genes in metastatic breast cancer cells and the stimulating effect of L: -serine on osteoclastogenesis and cancer cell proliferation indicate a functionally critical role for serine biosynthesis in bone metastatic breast cancer and thereby an opportunity for targeted therapeutic interventions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“High levels of PHGDH protein expression relative to normal tissue correlates with disease severity in breast cancer patients (Pollari et al., 2011).”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Pollari et al., 2011
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,893
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,082
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R. J., Parker, J. S., Hastie, T. J., Marron, J. S., Nobel, A. B., Deng, S., Johnsen, H., Pesich, R., Geisler, S. B., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,508
Summaries of Affymetrix GeneChip probe level data
Irizarry, R. A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng015 · Cited by 4,837
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Käkönen, S.-M., Cordon‐Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,605
Self-citationEvolving gene/transcript definitions significantly alter the interpretation of GeneChip data
Dai, M. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni179 · Cited by 1,807
WebGestalt: an integrated system for exploring gene sets in various biological contexts
Zhang, B., Kirov, S. A., & Snoddy, J. R. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki475 · Cited by 1,803
Miller, L. D., Smeds, J., George, J., Vega, V. B., Vergara, L. A., Ploner, A., Yudi Pawitan, Y., Hall, P. N., Klaar, S., Liu, E. T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506230102 · Cited by 1,256
Yin, J. J., Selander, K. S., Chirgwin, J. M., Dallas, M., Grubbs, B. G., Wieser, R., Massagué, J., Mundy, G. R., & Guise, T. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3523 · Cited by 988
Self-citation
Cited by
Sorted by citations
Items 201–272 of 272
Ma, J., Zhu, M. S., Ye, X., Wu, B., Wang, T., Ma, M., Li, T., & Zhang, N. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.959684 · Cited by 7
Alterations in bone metabolites with age in C57BL/6 mice model
Patel, D., Lee, T. J., Kumar, S., Vyavahare, S. S., Worth, A. M., Hill, W., Hamrick, M. W., Isales, C. M., Shinde, R. S., & Fulzele, S. (2022) · Biogerontology · doi:10.1007/s10522-022-09986-7 · Cited by 7
Amino Acid Metabolism in Bone Metastatic Disease
Edwards, D. N. (2023) · Current Osteoporosis Reports · doi:10.1007/s11914-023-00797-4 · Cited by 6
Metabolomics as a tool for understanding and treating triple-negative breast cancer
Khan, G., Hussain, M. S., Ahmad, S., Alam, N., Ali, S., & Alam, P. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04234-4 · Cited by 6
Hao, L., Li, B., Lü, S., An, Z.-C., Yin, Z.-Y., Du, Z., & Wang, H.-Q. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-025-01205-y · Cited by 5
Emerging roles for stromal cells in bone metastasis
Nyman, K. J., Frieling, J. S., & Lynch, C. C. (2024) · Journal of bone oncology · doi:10.1016/j.jbo.2024.100610 · Cited by 5
Ma, T., Ma, J., Wang, Y., Kui, X., Liu, J., Han, C., Wei, W., Lin, Z., & Song, X. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117182 · Cited by 5
Cui, Z., Mo, J., Wang, L., Wang, R., Cheng, F., Wang, L., Yang, X., & Wang, W. T. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.906291 · Cited by 5
Wang, J., He, X., Mi, Y., Chen, Y. Q., Li, J., & Wang, R. (2024) · BMC Cancer · doi:10.1186/s12885-024-12183-z · Cited by 5
The molecular crosstalk of the hippo cascade in breast cancer: A potential central susceptibility
Parambil, S. T., Antony, G. R., Littleflower, A. B., & Subhadradevi, L. (2024) · Biochimie · doi:10.1016/j.biochi.2024.03.008 · Cited by 5
Liu, K., He, L. F., Liu, Z., Xu, J., Liu, Y., Kuang, Q., Wen, Z., & Li, M. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1891-6 · Cited by 5
Metabolic reprogramming in bone metastasis of human cancers
Li, T., Wang, Z., Yang, H., & Kang, Y. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1711592 · Cited by 4
When Clocks Go Rogue: Circadian Rhythms and the Rise of Cancer
Robinson, A. S., Bennett, S. E., & Sato, S. (2026) · Journal of Biological Rhythms · doi:10.1177/07487304251391270 · Cited by 4
Lee, J. Y., Lim, W., Jo, G., Bazer, F. W., & Song, G. (2015) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2015.03.003 · Cited by 4
Deng, Y., Wu, D., Tachibana, H., & Cheng, X. (2015) · Parasitology Research · doi:10.1007/s00436-015-4317-2 · Cited by 4
Loss of NOL10 leads to impaired disease progression of NUP98::DDX10 leukemia
Shima, Y., Yamagata, K., Kuroki, Y., Sasaki, K., Aikawa, Y., & Kitabayashi, I. (2025) · Leukemia · doi:10.1038/s41375-025-02607-5 · Cited by 3
Amino acids and their roles in tumor immunotherapy of breast cancer
Xia, H., Zhu, J., Zheng, Z., Xiao, P., Yu, X., Wu, M., Xue, L., Xu, X. Y., Wang, X., Guo, Y., et al. (2023) · The Journal of Gene Medicine · doi:10.1002/jgm.3647 · Cited by 3
Breast Cancer Microenvironment and the Metastatic Process
Sflomos, G., & Brisken, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-48848-6_5 · Cited by 3
Metabolic Pathways of Eukaryotes and Connection to Cell Mechanics
Mierke, C. T. (2020) · Biological and medical physics, biomedical engineering · doi:10.1007/978-3-030-58532-7_17 · Cited by 2
Oxidative stress and cancer metabolism: From pathogenesis to therapeutic opportunities
Agnihotri, T. G., Gomte, S. S., Rout, B., Peddinti, V., Maharana, S. K., Yallappa, D., & Jain, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33459-7.00006-5 · Cited by 3
Interplay of Metastasis, Cancer Stem Cells, and Energy Metabolism in Cancer Progression
Mal, A. (2025) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-025-00059-8 · Cited by 2
Metabolic Reprogramming and the Control of Anoikis Resistance in Cancer
Sundararaman, A., Saha, M., Kumar, S., & Rangarajan, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-73856-3_2 · Cited by 2
Metabolic dysregulation in cancer progression
Arfin, S., Agrawal, K., Kumar, A., Kumar, A. J., Rathi, B., & Kumar, D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99879-6.00008-0 · Cited by 2
Khan, A., Siddiqui, S. I., Husain, S. A., Mazurek, S., & Iqbal, M. A. (2020) · doi:10.22541/au.160684227.70170021/v1 · Cited by 2
The l-Ser analog #290 promotes bone recovery in OP and RA mice
Bahtiar, A., Nakamura, T., Kishida, K., Katsura, J., Nitta, M., Ishida‐Kitagawa, N., Ogawa, T., & Takeya, T. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.05.004 · Cited by 1
OGT-mediated O-GlcNAcylation on GLDC promotes metastasis in cervical cancer
Cai, P., Jin, X., Zhu, H., Zhu, S., Wang, L., & Jin, J. (2018) · Oncotarget · doi:10.18632/oncotarget.24094 · Cited by 1
Identification of TAT as a Biomarker Involved in Cell Cycle and DNA Repair in Breast Cancer
Xie, F., Hua, S., Guo, Y., Wang, T., Shan, C., Zhang, L., & He, T. (2024) · Biomolecules · doi:10.3390/biom14091088 · Cited by 1
Li, A., Wu, Q., Xu, Y., Gu, Y., Wang, X., Liu, J., Wang, Y., Xie, J., Fu, X., & Li, Y. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70721
Pollari, S., Käkönen, R. S., Mohammad, K. S., Rissanen, J. P., Halleen, J. M., Wärri, A. M., Nissinen, L. M., Pihlavisto, M., Marjamäki, A., Perälä, M., et al. (2011) · Cancer Research · doi:10.1158/1538-7445.am2011-845 · Cited by 1
Self-citationMattaini, K. R., Sullivan, M. R., Lau, A. N., Fiske, B. P., Bronson, R. T., & Heiden, M. G. V. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/249250 · Cited by 1
The Fate of Glutamine in Human Metabolism. The interplay with glucose in proliferating cellsPreprint
Mazat, J., & Ransac, S. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/477224 · Cited by 1
The Relevance of the Mitochondrial H+-ATP Synthase in Cancer Biology
Martínez‐Reyes, I., & Cuezva, J. M. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1824-5_11
Wang, F., & Yang, Y. P. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3274-x
RetractedEdelson, S. (2011) · Science-Business eXchange · doi:10.1038/scibx.2011.842
Role of SIRT6 in Metabolic Reprogramming During Colorectal Carcinoma
Sebastián, C. (2014) · Defense Technical Information Center (DTIC) · doi:10.21236/ada614181
Tehoseulontatulosten validointi rintasyöpäsoluissa
Vikström, J. (2012) · Theseus (Ammattikorkeakoulujen)
RC-Specific Evaluation of P-Molmed - Personalized Molecular Medicine
Saari, S., & Moilanen, A. (2010)
Cilostazol Promotes the Migration of Brain Microvascular Endothelial Cells
Lee, S., Park, J. H., & Shin, H. K. (2016) · Journal of Life Science · doi:10.5352/jls.2016.26.12.1367
Suominen, M. I., Käkönen, R. S., Rissanen, J. P., Halleen, J. M., Härkönen, P. L., & Käkönen, S.-M. (2019) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2018.64
Self-citationFunctional consequence of PSAT1 association on PKM2's inherent enzymatic activity.
Vega, A. A. (2018) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3104
Investigation of phosphoserine aminotransferase 1(PSAT1) in breast cancer progression.
Metcalf, S. A. (2019) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3345
Villarreal, B., & Nadilly, Y. (2021) · Figshare
Energy metabolism in bone tumors
Bonnelye, E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00014-1
Biyik‐Sit, R. (2021) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3588
(2012) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e328350f70c
Vázquez, A., Markert, E. K., & Oltvai, Z. N. (2011) · Nature Precedings · doi:10.1038/npre.2011.6123.2
Vázquez, A., Markert, E. K., & Oltvai, Z. N. (2011) · Nature Precedings · doi:10.1038/npre.2011.6123
Transcriptomic analysis identified new lipid biomarkers for patient stratification in breast cancerPreprint
Din, Z. U., Cui, B., Wang, C., Ghayas, H., Peng, F., Haq, F. U., & Liu, Q. (2022) · Research Square · doi:10.21203/rs.3.rs-1837155/v1
Huang, M., Liu, X., Shao, Q., Zhang, X., Miao, L., Wu, X., Xu, Y., Wang, F., Wang, H., Zeng, L., et al. (2022) · Figshare · doi:10.6084/m9.figshare.17799228
Dietary Strategy for Cancer Therapy - Amino Acid Restrictions and beyond
Li, S., & Kang, J. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815223910124090003
You, M., & Kim, S. Y. (2025) · Research Square · doi:10.21203/rs.3.rs-7069883/v1
Wang, J., He, X., Mi, Y., Chen, Y. Q., Li, J., & Wang, R. (2024) · Figshare · doi:10.6084/m9.figshare.26706237
Jekabsons, M. B., Merrell, M., Skubiz, A. G., Thornton, N., Milasta, S., Green, D. R., Chen, T., Wang, Y.-H., Avula, B., Khan, I. A., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22615481
Wang, J., He, X., Mi, Y., Chen, Y. Q., Li, J., & Wang, R. (2024) · Figshare · doi:10.6084/m9.figshare.25599891
Wang, J., He, X., Mi, Y., Chen, Y. Q., Li, J., & Wang, R. (2024) · Figshare · doi:10.6084/m9.figshare.26706231
Additional file 4 of Dietary restriction of amino acids for Cancer therapy
Kang, J.-S. (2020) · Figshare · doi:10.6084/m9.figshare.11984706
Huang, M.-Y., Liu, X.-Y., Shao, Q., Zhang, X., Miao, L., Wu, X.-Y., Xu, Y.-X., Wang, F., Wang, H.-Y., Zeng, L., et al. (2022) · Figshare · doi:10.6084/m9.figshare.17799222
Wang, J., He, X., Mi, Y., Chen, Y. Q., Li, J., & Wang, R. (2024) · Figshare · doi:10.6084/m9.figshare.25599852
Wang, J., He, X., Mi, Y., Chen, Y. Q., Li, J., & Wang, R. (2024) · Figshare · doi:10.6084/m9.figshare.26706234
Zhao, X., Li, J., Hu, N., Wu, X., & Duan, J. (2026) · PLoS ONE · doi:10.1371/journal.pone.0340586
Yang, C., Li, Z., Li, G., Mi, H., & Qin, Y. (2026) · PLoS ONE · doi:10.1371/journal.pone.0341270
Spadazzi, C., Vanni, S., Vita, A. D., Cocchi, C., Gabellone, S., Miserocchi, G., Calabrese, C., Dellavalle, S., Cani, O., Tor, L. M. D., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.179800
Sun, C., Wu, S., Li, Z., Huang, C., & Wu, D. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118376
Metabolic Adaptation in Reprogrammed Cancer Cells
Marks, K. M., & Kung, C. K.-H. (2014) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-9545-1_7
Metadata
- Authors
- Pollari, S., Käkönen, S.-M., Edgren, H., Wolf, M., Kohonen, P., Sara, H., Guise, T., Nees, M., & Kallioniemi, O.
- Affiliations
- Turku Centre for Biotechnology (FI)
- University of Turku (FI)
- University of Helsinki (FI)
- Indiana University Indianapolis (US)
- Corresponding author
- Pollari, Sirkku
- ORCID
- Venue
- Breast Cancer Research and Treatment
- Published
- 2010-03-30
- Volume
- 125
- Issue
- 2
- Pages
- 421-430
- ISSN
- 0167-6806 (ISSN-L)
- 1573-7217
- OpenAlex
- W2014460958
- Cited by
- 269
- References
- 27
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 18 · 2023: 17 · 2022: 23 · 2021: 25 · 2020: 21 · 2019: 22 · 2018: 21 · 2017: 15 · 2016: 12 · 2015: 16 · 2014: 10 · 2013: 11 · 2012: 18
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Open access
- green
- hal.science
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Breast Cancer Research and Treatment (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Työväentutkimus Vuosikirja (submittedVersion, other-oa)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
- Funders
- National Cancer Institute (R01CA069158, R01 CA 69158)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- serine biosynthesis, breast cancer bone metastasis, osteoclastogenesis, L-serine, PHGDH, PSAT1, phosphoserine phosphatase, osteolytic bone metastasis, tumor cell proliferation, gene expression profiling, patient survival
- MeSH terms
- Transaminases, Animals, Bone Neoplasms, Bone Resorption, Breast Neoplasms, Cell Differentiation, Female, Humans, Mammary Neoplasms, Experimental, Neoplasm Transplantation, Osteoclasts, Phosphoric Monoester Hydrolases, Serine, Blotting, Western, Survival Rate, Polymerase Chain Reaction, Gene Expression Profiling, RNA, Small Interfering, Cell Line, Tumor, Cell Proliferation, Phosphoglycerate Dehydrogenase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review